Wang Jing, Chen TingRui, Gao Fei
Department of Endocrinology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.
Front Endocrinol (Lausanne). 2024 Dec 13;15:1492610. doi: 10.3389/fendo.2024.1492610. eCollection 2024.
Osteoporosis, a prevalent bone metabolic disorder, has emerged as a pressing global public health concern. Recent studies have illuminated a crucial link between ferroptosis and the pathogenesis of osteoporosis. Nevertheless, the intricate mechanisms underlying the role of ferroptosis in this condition remain largely unexplored. Therefore, this article comprehensively reviews the regulatory mechanisms of ferroptosis and the modulating effects on the development and progression of osteoporosis, as reported in recent years. Furthermore, this review summarizes the current state of the interventional strategies employed by both Western medicines and traditional Chinese medicines (TCMs) in addressing osteoporosis. This review aims to uncover potential novel avenues for the prevention and control of osteoporosis by synthesizing the modes of action and clinical efficacy of these therapeutic modalities.
骨质疏松症是一种常见的骨代谢紊乱疾病,已成为全球紧迫的公共卫生问题。最近的研究揭示了铁死亡与骨质疏松症发病机制之间的关键联系。然而,铁死亡在这种疾病中发挥作用的复杂机制在很大程度上仍未得到探索。因此,本文全面综述了近年来报道的铁死亡的调控机制及其对骨质疏松症发生发展的调节作用。此外,本综述总结了西药和中药在治疗骨质疏松症方面所采用的干预策略的现状。本综述旨在通过综合这些治疗方式的作用模式和临床疗效,探索预防和控制骨质疏松症的潜在新途径。